Table of Contents
Arthritis
Volume 2017, Article ID 6365857, 13 pages
https://doi.org/10.1155/2017/6365857
Research Article

Combination of Interleukin-27 and MicroRNA for Enhancing Expression of Anti-Inflammatory and Proosteogenic Genes

Department of Basic Medical Sciences, Purdue University College of Veterinary Medicine, West Lafayette, IN 47907, USA

Correspondence should be addressed to Marxa L. Figueiredo; ude.eudrup@ieugiflm

Received 19 August 2016; Revised 28 November 2016; Accepted 18 December 2016; Published 7 February 2017

Academic Editor: Shigeru Kotake

Copyright © 2017 Manoel Figueiredo Neto and Marxa L. Figueiredo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Van der Heijde, M. A. Van Leeuwen, P. L. Van Riel, and L. B. Van de Putte, “Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification),” Journal of Rheumatology, vol. 22, no. 9, pp. 1792–1796, 1995. View at Google Scholar · View at Scopus
  2. J. S. Stumhofer, A. Laurence, E. H. Wilson et al., “Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system,” Nature Immunology, vol. 7, no. 9, pp. 937–945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. O. Zolochevska, A. O. Diaz-Quiñones, J. Ellis, and M. L. Figueiredo, “Interleukin-27 expression modifies prostate cancer cell crosstalk with bone and immune cells in vitro,” Journal of Cellular Physiology, vol. 228, no. 5, pp. 1127–1136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Zolochevska, J. Ellis, S. Parelkar et al., “Interleukin-27 gene delivery for modifying malignant interactions between prostate tumor and bone,” Human Gene Therapy, vol. 24, no. 12, pp. 970–981, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S.-J. Moon, J.-S. Park, Y.-J. Heo et al., “In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritis,” Experimental & Molecular Medicine, vol. 45, no. 10, article e46, 2013. View at Publisher · View at Google Scholar
  6. R. M. Pope and S. Shahrara, “Possible roles of IL-12-family cytokines in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 9, no. 4, pp. 252–256, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. S. Iyer, A. A. Ghaffari, and G. Cheng, “Lipopolysaccharide-mediated IL-10 transcriptional regulation requires sequential induction of type I IFNs and IL-27 in macrophages,” The Journal of Immunology, vol. 185, no. 11, pp. 6599–6607, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. G. D. Kalliolias, B. Zhao, A. Triantafyllopoulou, K.-H. Park-Min, and L. B. Ivashkiv, “Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 402–413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Contreras and D. S. Rao, “MicroRNAs in inflammation and immune responses,” Leukemia, vol. 26, no. 3, pp. 404–413, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. O. Zolochevska and M. L. Figueiredo, “Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells,” Prostate, vol. 71, no. 4, pp. 353–367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Kozomara and S. Griffiths-Jones, “MiRBase: annotating high confidence microRNAs using deep sequencing data,” Nucleic Acids Research, vol. 42, no. 1, pp. D68–D73, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Pflanz, L. Hibbert, J. Mattson et al., “WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27,” The Journal of Immunology, vol. 172, no. 4, pp. 2225–2231, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Pflanz, J. C. Timans, J. Cheung et al., “IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells,” Immunity, vol. 16, no. 6, pp. 779–790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Schett and E. Gravallese, “Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment,” Nature Reviews Rheumatology, vol. 8, no. 11, pp. 656–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Clement, N. Gustafson, A. Berbert et al., “PathGen: a transitive gene pathway generator,” Bioinformatics, vol. 26, no. 3, pp. 423–425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Tsuji, N. Kraut, M. Groudine, and M. Noda, “Vitamin D3 enhances the expression of I-mfa, an inhibitor of the MyoD family, in osteoblasts,” Biochimica et Biophysica Acta—Molecular Cell Research, vol. 1539, no. 1-2, pp. 122–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. M. A. E. Schoeman, M. J. C. Moester, A. E. Oostlander et al., “Inhibition of GSK3β stimulates BMP signaling and decreases SOST expression which results in enhanced osteoblast differentiation,” Journal of Cellular Biochemistry, vol. 116, no. 12, pp. 2938–2946, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Saleh, L. Shan, A. J. Halayko, S. Kung, and A. S. Gounni, “Critical role for STAT3 in IL-17A-mediated CCL11 expression in human airway smooth muscle cells,” Journal of Immunology, vol. 182, no. 6, pp. 3357–3365, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. M. Onishi and S. L. Gaffen, “Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease,” Immunology, vol. 129, no. 3, pp. 311–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. O. Zolochevska, X. Xia, B. J. Williams, A. Ramsay, S. Li, and M. L. Figueiredo, “Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo,” Human Gene Therapy, vol. 22, no. 12, pp. 1537–1550, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Mizuno, Y. Tokuzawa, Y. Ninomiya et al., “miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b,” FEBS Letters, vol. 583, no. 13, pp. 2263–2268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Li, M. Q. Hassan, M. Jafferji et al., “Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation,” The Journal of Biological Chemistry, vol. 284, no. 23, pp. 15676–15684, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Mei, C. Bian, J. Li et al., “MiR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation,” Journal of Cellular Biochemistry, vol. 114, no. 6, pp. 1374–1384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. W. J. Boyle, W. S. Simonet, and D. L. Lacey, “Osteoclast differentiation and activation,” Nature, vol. 423, no. 6937, pp. 337–342, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Rossi, M. R. Pitari, N. Amodio et al., “miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease,” Journal of Cellular Physiology, vol. 228, no. 7, pp. 1506–1515, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Gao, J. McCormick, M. Connolly et al., “Hypoxia and STAT3 signalling interactions regulate pro-inflammatory pathways in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 74, no. 6, pp. 1275–1283, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. R. E. Barnett, D. J. Conklin, L. Ryan et al., “Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis,” Journal of Leukocyte Biology, vol. 99, no. 2, pp. 361–371, 2016. View at Google Scholar
  28. G.-X. Liu, Y.-Q. Li, X. R. Huang et al., “Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension,” Clinical Science, vol. 127, no. 3, pp. 195–208, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Fan, X. Jiang, X. Wu et al., “Anti-inflammatory activity of tanshinone IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and TLR4–NF-κB Pathway,” Inflammation, vol. 39, no. 1, pp. 375–384, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Ma, Y.-L. Luo, S.-J. Guo, L. Shen, and C.-W. Song, “Inhibitory effect of miR-20b on airway inflammation in asthmatic mice,” Journal of Southern Medical University, vol. 35, no. 10, pp. 1463–1466, 2015. View at Google Scholar · View at Scopus
  31. J. J. Sohn, A. J. Schetter, H. G. Yfantis et al., “Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease,” PLoS ONE, vol. 7, no. 9, Article ID e44156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Kumar, S. K. Sahu, M. Kumar et al., “MicroRNA 17-5p regulates autophagy in Mycobacterium tuberculosis-infected macrophages by targeting Mcl-1 and STAT3,” Cellular Microbiology, vol. 18, no. 5, pp. 679–691, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. M. P. Bell, P. A. Svingen, M. K. Rahman, Y. Xiong, and W. A. Faubion Jr., “FOXP3 regulates TLR10 expression in human T regulatory cells,” The Journal of Immunology, vol. 179, no. 3, pp. 1893–1900, 1893. View at Google Scholar